These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24140550)
1. Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis. Hatakeyama S; Amano M; Tobisawa Y; Yoneyama T; Tsuchiya N; Habuchi T; Nishimura S; Ohyama C J Urol; 2014 Mar; 191(3):805-13. PubMed ID: 24140550 [TBL] [Abstract][Full Text] [Related]
2. O-glycan profiling of serum glycan for potential renal cancer biomarkers. Gao Y; Ma F; Zhang W; Zhong F; Tang H; Xu D; Zhao L Sci China Life Sci; 2013 Aug; 56(8):739-44. PubMed ID: 23780530 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Kamiyama T; Yokoo H; Furukawa J; Kurogochi M; Togashi T; Miura N; Nakanishi K; Kamachi H; Kakisaka T; Tsuruga Y; Fujiyoshi M; Taketomi A; Nishimura S; Todo S Hepatology; 2013 Jun; 57(6):2314-25. PubMed ID: 23322672 [TBL] [Abstract][Full Text] [Related]
4. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma. Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans. Park CW; Jo Y; Jo EJ Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014 [TBL] [Abstract][Full Text] [Related]
6. Identification of two new serum protein profiles for renal cell carcinoma. Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783 [TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819 [TBL] [Abstract][Full Text] [Related]
8. Screening for the serum differential proteins of renal cell carcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Liu JS; Li HZ; Zhang YS; Wang P; Yan WG; Xie J; Dong DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Jun; 33(3):287-91. PubMed ID: 21718612 [TBL] [Abstract][Full Text] [Related]
9. Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer. Ishibashi Y; Tobisawa Y; Hatakeyama S; Ohashi T; Tanaka M; Narita S; Koie T; Habuchi T; Nishimura S; Ohyama C; Yoneyama T Prostate; 2014 Nov; 74(15):1521-9. PubMed ID: 25154914 [TBL] [Abstract][Full Text] [Related]
10. Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Chinello C; Gianazza E; Zoppis I; Mainini V; Galbusera C; Picozzi S; Rocco F; Galasso G; Bosari S; Ferrero S; Perego R; Raimondo F; Bianchi C; Pitto M; Signorini S; Brambilla P; Mocarelli P; Galli Kienle M; Magni F Urology; 2010 Apr; 75(4):842-7. PubMed ID: 19963255 [TBL] [Abstract][Full Text] [Related]
11. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372 [TBL] [Abstract][Full Text] [Related]
12. Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry. Amano M; Nishimura S Methods Enzymol; 2010; 478():109-25. PubMed ID: 20816476 [TBL] [Abstract][Full Text] [Related]
13. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Jeong HJ; Kim YG; Yang YH; Kim BG Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459 [TBL] [Abstract][Full Text] [Related]
15. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS]. Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509 [TBL] [Abstract][Full Text] [Related]
16. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [TBL] [Abstract][Full Text] [Related]
17. Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour. Johnson PJ; Poon TC; Hjelm NM; Ho CS; Ho SK; Welby C; Stevenson D; Patel T; Parekh R; Townsend RR Br J Cancer; 1999 Dec; 81(7):1188-95. PubMed ID: 10584881 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma. Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985 [TBL] [Abstract][Full Text] [Related]
19. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
20. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]